Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127709801 | 12770980 | 1 | I | 20160823 | 20160919 | 20160922 | 20160922 | EXP | US-PFIZER INC-2016441553 | PFIZER | 51.00 | YR | F | Y | 0.00000 | 20160922 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127709801 | 12770980 | 1 | PS | SILDENAFIL CITRATE. | SILDENAFIL CITRATE | 1 | UNK | U | 21845 | FILM-COATED TABLET | |||||||||
| 127709801 | 12770980 | 2 | SS | TYVASO | TREPROSTINIL | 1 | Respiratory (inhalation) | 54 UG, 4X/DAY, (9 BREATHS) | U | 0 | 54 | UG | INHALATION GAS | QID | |||||
| 127709801 | 12770980 | 3 | SS | AMBRISENTAN | AMBRISENTAN | 1 | 5 MG, 1X/DAY | U | 0 | 5 | MG | TABLET | QD | ||||||
| 127709801 | 12770980 | 4 | C | WARFARIN | WARFARIN | 1 | 0 | ||||||||||||
| 127709801 | 12770980 | 5 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 127709801 | 12770980 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 127709801 | 12770980 | 7 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 127709801 | 12770980 | 8 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | 0 | ||||||||||||
| 127709801 | 12770980 | 9 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 127709801 | 12770980 | 10 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 127709801 | 12770980 | 11 | C | OXYCODONE | OXYCODONE | 1 | 0 | ||||||||||||
| 127709801 | 12770980 | 12 | C | ATIVAN | LORAZEPAM | 1 | 0 | ||||||||||||
| 127709801 | 12770980 | 13 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127709801 | 12770980 | 2 | Pulmonary arterial hypertension |
| 127709801 | 12770980 | 3 | Pulmonary hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127709801 | 12770980 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127709801 | 12770980 | Aphonia | |
| 127709801 | 12770980 | Condition aggravated | |
| 127709801 | 12770980 | Dyspnoea | |
| 127709801 | 12770980 | Fluid retention | |
| 127709801 | 12770980 | Oropharyngeal pain | |
| 127709801 | 12770980 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127709801 | 12770980 | 2 | 20160418 | 0 | ||
| 127709801 | 12770980 | 3 | 20160204 | 0 |